Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01798784 · ClinicalTrials.gov registry record · NA
Habit Formation for Adherence to Statin Use and LDL Reduction
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 805
- Enrollment target
NCT01798784: Completed NA study, sponsored by University of Pennsylvania.
NCT01798784 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 805 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01798784, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 805 participants
- Enrollment target
Study Summary
In a 4-arm, Randomized Control Trial among members of CVS Caremark or Penn Medicine Patients with suboptimal cholesterol control who are at high risk for CVD, the study investigators propose to test the effectiveness of different behavioral economic techniques in inducing habit formation for adherence to statin use and sustained reductions in LDL cholesterol after financial incentives are discontinued. Primary outcome is changes in LDL from enrollment to 12 months (6 months after cessation of financial incentives).
Interventions
- BEHAVIORAL Sweepstake Incentive 1
- BEHAVIORAL Sweepstake Incentive 2
- BEHAVIORAL Sweepstake Incentive 3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 805 participants |
| Start Date | 2013-07 |
| Est. Completion | 2017-09 |
| Phase | NA |
What the finished NCT01798784 record still lists
NCT01798784 is an interventional study that assigns participants to a tested intervention. The registered 805 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower).
The record links to 0 conditions, and to 3 interventions - of which Sweepstake Incentive 1 is the first listed.
NCT01798784 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01798784 about?
NCT01798784 is a clinical study titled "Habit Formation for Adherence to Statin Use and LDL Reduction". In a 4-arm, Randomized Control Trial among members of CVS Caremark or Penn Medicine Patients with suboptimal cholesterol control who are at high risk for CVD, the study investigators propose to test the effectiveness of different behavioral economic techniques in inducing habit formation for adheren...
What is the current status of trial NCT01798784?
This trial is currently completed. It is a NA study. The enrollment target is 805 participants. The study started on 2013-07. Estimated completion is 2017-09.
What interventions are being tested in trial NCT01798784?
The interventions under investigation include: Sweepstake Incentive 1 (BEHAVIORAL), Sweepstake Incentive 2 (BEHAVIORAL), Sweepstake Incentive 3 (BEHAVIORAL).
Who is sponsoring clinical trial NCT01798784?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01798784's enrollment target sits among peer trials
805 134th of 2000 higher than 1,867 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04613596 · 806 participants · Phase 2
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- NCT06065098 · 806 participants · NA
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
- NCT04423211 · 804 participants · Phase 3
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- NCT06522022 · 804 participants · NA
PTSD Screening in Pregnant Black Women
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia